Neurosurgery Report Covers Cedars-Sinai’s BrightMatter Acquisition

“Cedars-Sinai neurosurgeons are using a high-definition imaging device to see inside the brain during surgery, allowing them to navigate safer pathways to reach and remove tumors,” wrote Neurosurgery Report in an article about the hospital’s acquisition of BrightMatter technology, which was posted January 3, 2017.

The article quotes Dr. Keith L. Black, MD, chair of Cedars-Sinai Department of Neurosurgery: “An estimated 62,000 primary brain tumors and 150,000 metastatic brain tumors are diagnosed annually in the U.S. This new tool offers us a tremendous amount of hope for better outcomes for many of our patients.”

In this video Dr. Black demonstrates how BrightMatter Guide works and explains its advantages in surgery.

Here’s an excerpt:

Cedars-Sinai is the first medical center in California to implement this system. This system offers a camera that tracks the neurosurgeon’s movements, showing a detailed image on a screen nearby. This tool can be used for operations on tumors, aneurysms, vascular lesions, skull-base issues and the spine.

Approximately 600 brain surgeries are performed per year at Cedars-Sinai. Moving forward, about a third of those procedures will utilize this new device.

Read the rest of Neurosurgery Report’s article on their website.


© Synaptive Medical, 2012-2019. All rights reserved.

Use of this webpage is subject to our terms of use and privacy policy. Images and video are for demonstrative purposes only. SYNAPTIVE, the Synaptive logo, BrightMatter, and Bridge are trademarks of Synaptive Medical Inc., or its subsidiaries. Patents Pending. Please contact Synaptive Medical for information on regulatory clearance status of our products in your jurisdiction.

Close Menu